生物化学传感器用于帕金森病的个性化治疗:我们站在哪里
Davide Ciarrocchi1, Pasquale Maria Pecoraro2,3, Alessandro Zompanti1
1Unit of Electronics for Sensor Systems, Department of Engineering, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Journal of clinical medicine
|December 17, 2024
概括
使用先进的生物化学传感器对levodopa的持续监测可以帮助管理帕金森病的运动波动. 这些传感器提供实时反,以优化治疗和改善患者的结果.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 分析化学 分析化学
背景情况:
- 利沃多巴是帕金森病 (PD) 的首要治疗方法.
- 晚期PD阶段缩小了勒沃多巴的治疗窗口,导致运动波动和运动障碍.
- 缺乏持续的运动监测生物标志物使治疗优化变得复杂.
研究的目的:
- 审查用于Levodopa和Catecholamine监测的生化传感方面的进展.
- 探索用于PD实时治疗反的新兴技术.
- 评估传感器在开发帕金森病闭环治疗中的潜力.
主要方法:
- 综述各种乐伏多巴检测技术:微透析,电化学 (非酶,酶).
- 专注于电化学传感,包括可穿戴 (反向离子泳,微针) 和护理点设备.
- 纳米材料 (碳纳米管,MOF,石墨烯) 的整合,以提高传感器的性能.
主要成果:
- 电化学传感器,特别是护理点设备,为乐伏多巴监测提供了高性能.
- 纳米材料显著提高了传感器的灵敏度,选择性和检测极限.
- 在生物流体 (汗水,间歇液体) 中进行持续监测是可行的,以实时评估.
结论:
- 对levodopa的生物化学感知是实时治疗反的有希望的方法.
- 准确的,持续的监测可以帮助管理帕金森病的运动性能.
- 新兴的传感器技术为PD的闭环治疗系统铺平了道路.
相关概念视频
Parkinson's Disease: Treatment
216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


